CD8A and ataxia telangiectasia: The specific aim of our study was to predict the fate and antiviral efficacies of transferred donor-derived CMV-specific memory CD8 T cells and their activation subsets in immunocompromised and CMV-infected, potential HCT recipients in the well-defined mouse model of syngeneic AT (reviewed in [50,70]).